Loading...
ICON plc reported a challenging first quarter of 2025 with revenue and bookings below expectations due to market volatility and delays in customer decision making. Despite revenue pressure, adjusted EBITDA margin and EPS were in line with expectations due to cost control. Full-year 2025 guidance was updated, primarily excluding two large next-generation COVID vaccine trials.
ICON reported Q4 2024 revenue of $2.04 billion, a 1.2% decrease from the prior year. Net income increased to $260 million, and adjusted EPS reached $3.43. The company also reported strong free cash flow and reaffirmed its full-year 2025 financial guidance.